Date: Thursday, May 23, 2019Time: 10AM PDT | 1PM EDTSpeaker: Dr. Ankita DasCheckpoint inhibitors have produced durable responses, even cure, in patients who have failed all therapies. This phenomenon is unprecedented in cancer treatment...
Read More »Upcoming Webinar – Accurate prediction of vaccine candidates using a novel HLA-peptide-TCR-binding tool: OncopeptVAC™ and their validation by OncoPeptSCRN
Wednesday, July 25, 2018 10AM PDT | 1PM EDT | 6PM BST | 7PM CEST Checkpoint inhibitors have opened new avenues for treating cancer, however patients treated with these drugs often show poor durability or responsiveness to treatment, and immune toxicity...
Read More »